What Covered Entities Need to Know
Starting next year, two major changes will impact how select outpatient prescription drugs are paid for and accessed: the 340B Rebate Model Pilot Program and the first year of Maximum Fair Prices (MFPs) under the Medicare Drug Price Negotiation Program, established by the Inflation Reduction Act (IRA). Read More >



